NSE (ALNSE.PA) Fundamental Analysis & Valuation

EPA:ALNSE • FR0004065639

Current stock price

48.2 EUR
0 (0%)
Last:

This ALNSE.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. ALNSE.PA Profitability Analysis

1.1 Basic Checks

  • ALNSE had positive earnings in the past year.
  • In the past year ALNSE had a positive cash flow from operations.
  • Each year in the past 5 years ALNSE has been profitable.
  • Of the past 5 years ALNSE 4 years had a positive operating cash flow.
ALNSE.PA Yearly Net Income VS EBIT VS OCF VS FCFALNSE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

1.2 Ratios

  • The Return On Assets of ALNSE (2.11%) is worse than 60.71% of its industry peers.
  • The Return On Equity of ALNSE (4.58%) is worse than 67.86% of its industry peers.
  • ALNSE's Return On Invested Capital of 7.73% is in line compared to the rest of the industry. ALNSE outperforms 57.14% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ALNSE is in line with the industry average of 9.83%.
Industry RankSector Rank
ROA 2.11%
ROE 4.58%
ROIC 7.73%
ROA(3y)4.86%
ROA(5y)5.44%
ROE(3y)9.24%
ROE(5y)10.68%
ROIC(3y)9.24%
ROIC(5y)10.98%
ALNSE.PA Yearly ROA, ROE, ROICALNSE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

  • With a Profit Margin value of 2.09%, ALNSE is not doing good in the industry: 67.86% of the companies in the same industry are doing better.
  • In the last couple of years the Profit Margin of ALNSE has declined.
  • ALNSE has a worse Operating Margin (5.38%) than 67.86% of its industry peers.
  • In the last couple of years the Operating Margin of ALNSE has declined.
  • With a decent Gross Margin value of 45.65%, ALNSE is doing good in the industry, outperforming 78.57% of the companies in the same industry.
  • ALNSE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 5.38%
PM (TTM) 2.09%
GM 45.65%
OM growth 3Y-10.36%
OM growth 5Y-11.66%
PM growth 3Y-17.04%
PM growth 5Y-14.59%
GM growth 3Y-13.53%
GM growth 5Y-7.43%
ALNSE.PA Yearly Profit, Operating, Gross MarginsALNSE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

7

2. ALNSE.PA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ALNSE is still creating some value.
  • Compared to 1 year ago, ALNSE has about the same amount of shares outstanding.
  • Compared to 5 years ago, ALNSE has more shares outstanding
  • The debt/assets ratio for ALNSE has been reduced compared to a year ago.
ALNSE.PA Yearly Shares OutstandingALNSE.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
ALNSE.PA Yearly Total Debt VS Total AssetsALNSE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • An Altman-Z score of 3.99 indicates that ALNSE is not in any danger for bankruptcy at the moment.
  • ALNSE has a Altman-Z score of 3.99. This is in the better half of the industry: ALNSE outperforms 75.00% of its industry peers.
  • The Debt to FCF ratio of ALNSE is 1.73, which is an excellent value as it means it would take ALNSE, only 1.73 years of fcf income to pay off all of its debts.
  • ALNSE's Debt to FCF ratio of 1.73 is amongst the best of the industry. ALNSE outperforms 83.93% of its industry peers.
  • ALNSE has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
  • ALNSE has a Debt to Equity ratio of 0.10. This is amongst the best in the industry. ALNSE outperforms 87.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 1.73
Altman-Z 3.99
ROIC/WACC0.95
WACC8.16%
ALNSE.PA Yearly LT Debt VS Equity VS FCFALNSE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

  • ALNSE has a Current Ratio of 1.70. This is a normal value and indicates that ALNSE is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of ALNSE (1.70) is better than 78.57% of its industry peers.
  • A Quick Ratio of 1.33 indicates that ALNSE should not have too much problems paying its short term obligations.
  • ALNSE has a Quick ratio of 1.33. This is amongst the best in the industry. ALNSE outperforms 83.93% of its industry peers.
Industry RankSector Rank
Current Ratio 1.7
Quick Ratio 1.33
ALNSE.PA Yearly Current Assets VS Current LiabilitesALNSE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

6

3. ALNSE.PA Growth Analysis

3.1 Past

  • The earnings per share for ALNSE have decreased strongly by -58.64% in the last year.
  • ALNSE shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.31% yearly.
  • The Revenue has been growing slightly by 3.20% in the past year.
  • Measured over the past years, ALNSE shows a small growth in Revenue. The Revenue has been growing by 6.37% on average per year.
EPS 1Y (TTM)-58.64%
EPS 3Y-3.88%
EPS 5Y-9.31%
EPS Q2Q%-57.73%
Revenue 1Y (TTM)3.2%
Revenue growth 3Y15.84%
Revenue growth 5Y6.37%
Sales Q2Q%-6.51%

3.2 Future

  • ALNSE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.88% yearly.
  • ALNSE is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 32.29% yearly.
EPS Next Y30.58%
EPS Next 2Y45.97%
EPS Next 3Y35.88%
EPS Next 5YN/A
Revenue Next Year64.79%
Revenue Next 2Y17.73%
Revenue Next 3Y32.29%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALNSE.PA Yearly Revenue VS EstimatesALNSE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
ALNSE.PA Yearly EPS VS EstimatesALNSE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2 3

4

4. ALNSE.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 74.15, ALNSE can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Earnings ratio of ALNSE is on the same level as its industry peers.
  • The average S&P500 Price/Earnings ratio is at 25.50. ALNSE is valued rather expensively when compared to this.
  • With a Price/Forward Earnings ratio of 15.10, ALNSE is valued correctly.
  • Based on the Price/Forward Earnings ratio, ALNSE is valued cheaper than 96.43% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 22.67. ALNSE is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 74.15
Fwd PE 15.1
ALNSE.PA Price Earnings VS Forward Price EarningsALNSE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ALNSE is valued a bit cheaper than 69.64% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALNSE is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 42.86
EV/EBITDA 16.7
ALNSE.PA Per share dataALNSE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • ALNSE's earnings are expected to grow with 35.88% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.42
PEG (5Y)N/A
EPS Next 2Y45.97%
EPS Next 3Y35.88%

4

5. ALNSE.PA Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.54%, ALNSE is not a good candidate for dividend investing.
  • ALNSE's Dividend Yield is comparable with the industry average which is at 0.73.
  • Compared to an average S&P500 Dividend Yield of 1.89, ALNSE's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.54%

5.2 History

  • The dividend of ALNSE is nicely growing with an annual growth rate of 22.60%!
Dividend Growth(5Y)22.6%
Div Incr Years2
Div Non Decr Years5
ALNSE.PA Yearly Dividends per shareALNSE.PA Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.05 0.1 0.15 0.2 0.25

5.3 Sustainability

  • 41.18% of the earnings are spent on dividend by ALNSE. This is a bit on the high side, but may be sustainable.
  • ALNSE's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP41.18%
EPS Next 2Y45.97%
EPS Next 3Y35.88%
ALNSE.PA Yearly Income VS Free CF VS DividendALNSE.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M
ALNSE.PA Dividend Payout.ALNSE.PA Dividend Payout, showing the Payout Ratio.ALNSE.PA Dividend Payout.PayoutRetained Earnings

ALNSE.PA Fundamentals: All Metrics, Ratios and Statistics

NSE

EPA:ALNSE (3/24/2026, 7:00:00 PM)

48.2

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)01-28
Earnings (Next)N/A
Inst Owners22.33%
Inst Owner ChangeN/A
Ins Owners64.28%
Ins Owner ChangeN/A
Market Cap162.92M
Revenue(TTM)99.97M
Net Income(TTM)2.09M
Analysts86.67
Price Target64.97 (34.79%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.54%
Yearly Dividend0.25
Dividend Growth(5Y)22.6%
DP41.18%
Div Incr Years2
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.47%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-4.04%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)23.26%
Revenue NY rev (3m)23.26%
Valuation
Industry RankSector Rank
PE 74.15
Fwd PE 15.1
P/S 1.63
P/FCF 42.86
P/OCF 21.37
P/B 3.56
P/tB 4.03
EV/EBITDA 16.7
EPS(TTM)0.65
EY1.35%
EPS(NY)3.19
Fwd EY6.62%
FCF(TTM)1.12
FCFY2.33%
OCF(TTM)2.26
OCFY4.68%
SpS29.58
BVpS13.52
TBVpS11.96
PEG (NY)2.42
PEG (5Y)N/A
Graham Number14.06
Profitability
Industry RankSector Rank
ROA 2.11%
ROE 4.58%
ROCE 10.31%
ROIC 7.73%
ROICexc 10.37%
ROICexgc 12%
OM 5.38%
PM (TTM) 2.09%
GM 45.65%
FCFM 3.8%
ROA(3y)4.86%
ROA(5y)5.44%
ROE(3y)9.24%
ROE(5y)10.68%
ROIC(3y)9.24%
ROIC(5y)10.98%
ROICexc(3y)11.65%
ROICexc(5y)13.8%
ROICexgc(3y)13.37%
ROICexgc(5y)15.81%
ROCE(3y)12.32%
ROCE(5y)14.64%
ROICexgc growth 3Y-2.2%
ROICexgc growth 5Y-7.13%
ROICexc growth 3Y-2.56%
ROICexc growth 5Y-7.79%
OM growth 3Y-10.36%
OM growth 5Y-11.66%
PM growth 3Y-17.04%
PM growth 5Y-14.59%
GM growth 3Y-13.53%
GM growth 5Y-7.43%
F-Score5
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 1.73
Debt/EBITDA 0.52
Cap/Depr 108.86%
Cap/Sales 3.82%
Interest Coverage 29.25
Cash Conversion 85.72%
Profit Quality 181.61%
Current Ratio 1.7
Quick Ratio 1.33
Altman-Z 3.99
F-Score5
WACC8.16%
ROIC/WACC0.95
Cap/Depr(3y)97.38%
Cap/Depr(5y)100.98%
Cap/Sales(3y)3.76%
Cap/Sales(5y)3.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-58.64%
EPS 3Y-3.88%
EPS 5Y-9.31%
EPS Q2Q%-57.73%
EPS Next Y30.58%
EPS Next 2Y45.97%
EPS Next 3Y35.88%
EPS Next 5YN/A
Revenue 1Y (TTM)3.2%
Revenue growth 3Y15.84%
Revenue growth 5Y6.37%
Sales Q2Q%-6.51%
Revenue Next Year64.79%
Revenue Next 2Y17.73%
Revenue Next 3Y32.29%
Revenue Next 5YN/A
EBIT growth 1Y-23.17%
EBIT growth 3Y3.84%
EBIT growth 5Y-6.03%
EBIT Next Year110.2%
EBIT Next 3Y55.39%
EBIT Next 5YN/A
FCF growth 1Y26.36%
FCF growth 3Y-2.62%
FCF growth 5Y6.82%
OCF growth 1Y22.3%
OCF growth 3Y-2.36%
OCF growth 5Y8.53%

NSE / ALNSE.PA Fundamental Analysis FAQ

What is the fundamental rating for ALNSE stock?

ChartMill assigns a fundamental rating of 5 / 10 to ALNSE.PA.


Can you provide the valuation status for NSE?

ChartMill assigns a valuation rating of 4 / 10 to NSE (ALNSE.PA). This can be considered as Fairly Valued.


How profitable is NSE (ALNSE.PA) stock?

NSE (ALNSE.PA) has a profitability rating of 3 / 10.


What is the valuation of NSE based on its PE and PB ratios?

The Price/Earnings (PE) ratio for NSE (ALNSE.PA) is 74.15 and the Price/Book (PB) ratio is 3.56.


Can you provide the financial health for ALNSE stock?

The financial health rating of NSE (ALNSE.PA) is 7 / 10.